Skip to main content
R&D

Three new projects certified in July 2018 have just been added to the BioWin cluster's project portfolio.

The portfolio is now counting 47 projetcs

BENEFIT (Biostatistical Estimation of Net Effects for Individualization of Therapy) is joining the "data science" topic. Coordinated by IDDI, the project is aiming to develop a new statistical method (Generalised Pairwise Comparisons) and to create software for designing and analysing clinical trials using this innovative approach which will be of interest to all stakeholders, including patients. To successfully complete this 30-month project with a budget of €1.8 million, IDDI is collaborating with four other partners: Brystol-Myers Squibb, UCL (Institute of biostatistics and actuarial sciences), EORTC and the University Hospital of Lyon.

This project is set to start on 26 September.

CQIntégré is run by Trasis and comes under the topic radiation applied to health. In partnership with Taipro and two academic laboratories of the ULB (nuclear medicine service, TEP unit) and the UCL (ELEN Department), the consortium aims to develop an integrated and compact system dedicated to quality control (QC) of radioactive pharmaceutical products used in nuclear medicine procedures. The budget allocated for this 36 month project is €2.7 million. It is planned to start in mid-September 2018.

e-Lisa is an innovative approach to respiratory problems during sleep. This project is run by Neomalabs. The aim is to develop a connected, miniaturised and user-friendly stimulator, re-educating the masseter muscles while sleeping.

Three new projects certified in July 2018 have just been added to the BioWin cluster's project portfolio.